摘要
《中国缺血性中风中成药合理使用指导规范》是由国家卫生计生委脑卒中防治工程委员会、脑卒中防治系列指导规范编审委员会组织编写的一部临床规范指南,经过多名中西医专家反复论证,以期在全国范围内推广应用。为进一步让临床医生、卫生政策制定者以及相关研究人员深入了解和恰当使用该规范,文章将围绕该规范的制订背景、编制体系特点及问题展望等方面做解读。
The Guidelines for the Rational Use of Chinese Patent Medicine for Ischemic Stroke in China is a clinical normative guide compiled and repeatedly demonstrated by several Chinese and western medicine experts in the organization of National Health and Family Planning Commission’s Stroke Prevention and Control Engineering Committee and the Stroke Prevention and Control Series Regulatory Review Committee,aiming to promote the application in the national scope.In order to induce clinicians,health policy makers,and related researchers to understand it deeply and use it rationally,this article will focus on the formulation,the characteristics of the preparation system,and the outlook for the problem of this guidelines.
作者
高维
王建伟
郭蓉娟
GAO Wei;WANG Jian-wei;GUO Rong-juan(Beijing University of Chinese Medicine,Beijing 100029,China;Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,China;Dongfang Hospital,Beijing University of Chinese Medicine,Beijing 100078,China)
出处
《中华中医药杂志》
CAS
CSCD
北大核心
2020年第2期581-584,共4页
China Journal of Traditional Chinese Medicine and Pharmacy
基金
国家重点基础研究发展计划(973计划)(No.2015C B554401)
2011年医改重大专项“卫生部脑卒中高危人群筛查与干预试点项目”
北京中医药大学优秀传承团队项目——王永炎名医传承站(No.1000062720028/010)。
关键词
缺血性中风
中成药
指导规范
解读
Ischemic stroke
Chinese patent medicine
Guidelines
Interpretation
